Homemyovaterra.comcrumbs.should-every-embry...
Logo
Nov 12, 2026 6:12 PM

Should Every Embryo Reach the Blastocyst Stage?

Shop now
Should Every Embryo Reach the Blastocyst Stage?
Nov 12, 2026 6:12 PM

Should Every Embryo Reach the Blastocyst Stage?

Shop now

FRMC 2026: Questioning Established Practices in Reproductive Medicine

1. Contents of the Newsletter

The newsletter, titled "Should Every Embryo Reach the Blastocyst Stage?", was sent by the Foundation for Reproductive Medicine (FRM) to promote the FRMC 2026 Foundation for Reproductive Medicine Conference. Its central theme is "Think Differently," a call to reexamine assumptions that guide daily decisions in IVF clinics and laboratories. The message is organized around several main sections.

Is Blastocyst Culture Always the Right Choice?

The lead feature introduces Prof. Raoul Orvieto, MD, who will address whether all embryos should be cultured to the blastocyst stage. Blastocyst culture plays a central role in modern embryology, and the newsletter suggests that familiar practices deserve closer scrutiny. The article also raises broader questions: how often clinicians reconsider the assumptions behind their decisions, and how they determine whether an established approach suits different patients. The presentation is scheduled for Session 5A, "Driving Towards Precision Medicine in Reproductive Endocrinology and Fertility."

Why Egg Morphology Doesn't Tell the Whole Story

The second feature highlights Cari Nicholas, PhD, who will speak in the same morning session. Her talk examines why neither an egg's morphology (its physical appearance) nor its maturity fully indicates its quality or potential.

The Conference Philosophy

The newsletter frames both presentations as examples of the scientific approach FRMC was built to encourage: questioning established practices, examining evidence, and looking beyond conventional assumptions. It concludes that progress in reproductive medicine often comes not only from new technologies but also from critically reviewing current decisions.

Event Details

  • Dates: December 4-6, 2026
  • Venue: Metropolitan Club, One East 60th Street, New York City
  • Calls to action: "View the Program" and "Register Now"

Featured Faculty

The newsletter showcases an international lineup of speakers, including G. David Adamson, David F. Albertini, Christine S. Allen, Claus Yding Andersen, David H. Barad, Norbert Gleicher, Kyle Orwig, Pasquale Patrizio, David Pépin, Juan Carlos Izpisua-Belmonte, Zev Williams, Nikica Zaninovic, Joanne Kwak-Kim, and many others, alongside Cari Nicholas and Raoul Orvieto.

Sponsors and Exhibitors

Ferring Pharmaceuticals is listed as the Gold Sponsor. Other sponsors and exhibitors named include AOM Infusion, Center for Human Reproduction, Ovaterra (tagline: "Revolutionizing Fertility Health"), Natera ("Conceive. Deliver. Thrive."), ViaCord, Revvity, and Labcorp, along with Reproductive Times.

2. Products and Offerings

The newsletter does not describe any specific fertility products, devices, or treatments in detail. The only concrete offerings are the conference registration categories for FRMC 2026:

  • Physician (commercial): $1,350
  • Academic, Lawyers, and Investors: $850
  • Residents, Fellows, and NPs: $850
  • Patients (current and former CHR patients): $500
  • Medical students: Free

The organizers state that there are no additional fees in any category. Beyond registration, the text contains no product descriptions, pricing for medical services, or purchasing details.

3. About the Store: myovaterra.com

The newsletter itself was sent by the Foundation for Reproductive Medicine, not by Ovaterra. Ovaterra appears only as one of the conference's sponsors and exhibitors, under the tagline "Revolutionizing Fertility Health." The message provides no information about the company's product range, business model, website features, or customer policies, so a detailed profile of the myovaterra.com store cannot be drawn from this newsletter alone.

What can be said is that Ovaterra chose to align itself with a respected professional forum focused on evidence-based reproductive medicine and critical thinking. Its presence among sponsors such as Ferring Pharmaceuticals and Natera suggests that it operates within the fertility health sector and seeks visibility among clinicians, researchers, and patients. Readers who want to learn about the company's offerings should visit myovaterra.com directly.

Relevant newsletters

Beyond the Main Stage at FRMC 2026

Beyond the Main Stage at FRMC 2026

Nov 17, 2026 6:01 PM
myovaterra.com
Read now
A Healthier Approach to Everyday Wellness

A Healthier Approach to Everyday Wellness

Nov 16, 2026 3:00 PM
myovaterra.com
Read now
This Thanksgiving, Thank Your Body

This Thanksgiving, Thank Your Body

Nov 11, 2026 2:30 PM
myovaterra.com
Read now